Jupiter Wellness Acquisition - Tradeable Rights - Dec 2026's common stock is $140M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
The latest common stock for JWACR is $140M as of March 2023. That compares with $140M in the prior-year period — up 3.9% year over year. Investors often review this figure alongside Jupiter Wellness Acquisition - Tradeable Rights - Dec 2026's historical trend and sector peers before judging valuation or financial health.
Over the past year, JWACR's common stock moved from $140M to $140M — a 3.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Jupiter Wellness Acquisition - Tradeable Rights - Dec 2026's operating scale or balance-sheet position.
A common stock figure of $140M for JWACR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting JWACR's common stock ($140M), review year-over-year change from $140M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.